Effective medical education solutions for HCPs and patients
Experience expert–curated hubs and patient programs – created, updated, and endorsed by expert steering committees and medical societies for medical and healthcare professionals, patients, and caregivers.
Our hubs
SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide.
Information overload solved
In lymphoma alone, around 15,000 clinical papers were published in 2023, which equates to nearly 40 papers a day or 2 every hour! This, combined with the complexity of diseases and the disparate nature of where the data/information is located, has resulted in the opportunity to support community healthcare professionals by providing everything related to a disease in one place: Our hubs.
Helping increase knowledge of upcoming therapeutics
We curate a continual flow of news and updates, allowing swift integration into clinical practice, so HCPs are best placed to support their patients.
Endorsed by expert societies
We work closely with expert societies and world opinion leaders, ensuring credibility and trust in the quality of our content, thus increasing the chance of time-limited HCPs engaging with our content.
Reaching over 6 million HCPs annually
Our educational platforms have a wide global reach, have an average satisfaction score of 4.6/5, and improve the knowledge of 39% of HCPs who engage with our content.
Designed to solve educational needs
Knowledge gaps are identified by our expert steering committee and patients, so we can ensure our content supports HCPs in improving patient outcomes.
Curating content designed to be digested in minutes
We support time-poor HCPs to expedite their learning, delivered in impactful, easily digestible micro-learning formats.
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Graft-versus-host disease (GvHD)
Lymphoma and chronic lymphocytic leukemia (CLL)
Lupus
Multiple myeloma
Myeloproliferative neoplasms (MPN)
Psoriasis and psoriatic arthritis (PsOPsA)
Co-chaired by
Charles Mullighan
St. Jude Children’s Research Hospital, Memphis, US
Hervé Dombret
Université de Paris, Paris, FR
Franco Locatelli
Bambino Gesù Children’s Hospital, Rome, IT
In partnership with
The European School of Haematology (ESH)
Commitment to IME integrity and standards
Scientific Education Support (SES) is a member of the Good CME Practice Group, which means that all Independent Medical Education (IME) and Continuing Medical Education (CME) materials created for the hubs provide a fair and balanced overview, free from bias with no influence from the financial supporters.
Our patient programs
Our patient programs aim to provide patients and carers with a voice, so they can share their experiences and challenges. We collaborate very closely with our patient societies to ensure our work is effective at delivering disease and treatment awareness for patients and carers worldwide.
Putting patients first
Patients are so often overlooked as partners within the treatment team. Our strategy and tactics are guided by what patients tell us. Our regular global campaigns engage with communities to increase understanding, help people to recognize symptoms early, and empower them to become partners in their own care.
Collaboration at the heart
We work with those who support patients in achieving a better experience of the health service and an improved quality of life.
Driven by science
Our programs are supported by the latest scientific research to ensure they provide effective solutions.
Disseminated across the world
Over 50 patient societies work with us to reach a truly global audience.
Acute myeloid leukemia (AML)
Acute lymphoblastic leukemia (ALL)
International Waldenstrom's Macroglobulinemia Foundation (IWMF)